I 118th CONGRESS 1st Session H. R. 206 IN THE HOUSE OF REPRESENTATIVES January 9, 2023 Mr. Schweikert introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend the Federal Food, Drug, and Cosmetic Act to clarify that artificial intelligence and machine learning technologies can qualify as a practitioner eligible to prescribe drugs if authorized by the State involved and approved, cleared, or authorized by the Food and Drug Administration, and for other purposes.

1. Short title This Act may be cited as the Healthy Technology Act of 2023 . 2. Prescription of drugs by artificial intelligence or machine learning technologies Section 503(b) of Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 353(b) ) is amended by adding at the end the following: (6) In this subsection, the term practitioner licensed by law to administer such drug includes artificial intelligence and machine learning technology that are— (A) authorized pursuant to a statute of the State involved to prescribe the drug involved; and (B) approved, cleared, or authorized under section 510(k), 513, 515, or 564. .